Profile data is unavailable for this security.
About the company
Astena Holdings Co Ltd, formerly Iwaki & Co Ltd is a Japan-based company primarily engaged in the fine chemicals business, medical business, health & beauty care (HBC) and food business, and industrial chemicals business. The Company operates through four business segments. The Fine Chemicals segment is engaged in manufacture and sale of pharmaceutical raw materials and pharmaceuticals. The Medical segment is engaged in the manufacturing and sales of pharmaceutical products. The HBC and Food segment is engaged in the manufacture and sale of cosmetic raw materials, functional food raw materials, general use medicines and related products, as well as cosmetics. The Industrial Chemicals segment manufactures and sells chemicals for electronic industries, surface treatment chemicals, chemical products, surface treatment chemical raw materials, as well as to printed circuit board and other manufacturing plants. The other businesses include consulting services and others.
- Revenue in JPY (TTM)52.63bn
- Net income in JPY1.62bn
- Incorporated1941
- Employees1.40k
- LocationAstena Holdings Co Ltd4-8-2, Nihombashi Hon-choCHUO-KU 103-8403JapanJPN
- Phone+81 332790481
- Fax+81 332713240
- Websitehttps://www.astena-hd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kohjin Bio Co Ltd | 4.77bn | 384.98m | 11.81bn | 159.00 | 25.04 | 3.47 | 17.26 | 2.48 | 92.30 | 92.30 | 1,122.07 | 666.48 | -- | -- | -- | 30,000,600.00 | -- | -- | -- | -- | 39.44 | -- | 8.07 | -- | 1.14 | -- | 0.4249 | -- | 0.5715 | -- | -53.61 | -- | -- | -- |
| Oncolys Biopharma Inc | 28.04m | -1.98bn | 12.77bn | 34.00 | -- | 7.24 | -- | 455.30 | -107.77 | -107.77 | 1.52 | 84.14 | 0.0127 | 0.00 | 0.1476 | 824,647.10 | -89.46 | -45.75 | -101.52 | -51.86 | 100.00 | 60.46 | -7,058.44 | -233.66 | 8.82 | -- | 0.1416 | -- | -93.54 | -17.86 | -68.72 | -- | 28.18 | -- |
| ReproCell Inc | 2.43bn | -31.42m | 13.21bn | 96.00 | -- | 1.54 | 2,317.40 | 5.44 | -0.3466 | -0.3466 | 28.34 | 93.45 | 0.2788 | 5.41 | 5.60 | 25,279,340.00 | -0.3609 | -7.35 | -0.3932 | -8.00 | 46.19 | 39.83 | -1.29 | -27.16 | 10.54 | -- | 0.00 | -- | -17.83 | 17.39 | 89.71 | -- | 13.27 | -- |
| RaQualia Pharma Inc | 2.18bn | -253.40m | 13.81bn | 67.00 | -- | 2.30 | -- | 6.33 | -11.72 | -11.72 | 100.79 | 277.21 | 0.247 | 2.76 | 3.03 | 32,526,720.00 | -2.87 | 2.13 | -3.18 | 2.26 | 88.70 | 88.49 | -11.63 | 5.32 | 3.53 | -- | 0.4031 | 0.00 | -34.85 | 20.62 | -144.74 | -- | 0.0967 | -- |
| Symbio Pharmaceuticals Ltd | 4.64bn | -2.74bn | 14.23bn | 109.00 | -- | 1.98 | -- | 3.07 | -66.88 | -66.88 | 113.80 | 156.38 | 0.5439 | 2.76 | 5.14 | 42,594,130.00 | -32.15 | -19.18 | -35.33 | -23.62 | 78.38 | 65.84 | -59.12 | -24.32 | 10.43 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Stella Pharma Corp | 269.49m | -763.75m | 14.45bn | 44.00 | -- | 5.70 | -- | 53.63 | -24.63 | -24.63 | 8.70 | 76.12 | 0.0661 | 0.0508 | 3.98 | 6,124,796.00 | -18.74 | -22.50 | -21.00 | -24.83 | 80.63 | -- | -283.40 | -488.65 | 5.52 | -1,319.97 | 0.2819 | -- | 17.65 | -- | 1.94 | -- | -5.87 | -- |
| Ohki Healthcare Holdings Co Ltd | 334.66bn | 2.21bn | 14.55bn | 632.00 | 6.44 | 0.5067 | 5.81 | 0.0435 | 160.45 | 160.45 | 24,293.96 | 2,040.70 | 2.56 | 13.33 | 4.80 | 529,526,900.00 | 1.63 | 1.85 | 7.07 | 8.42 | 5.14 | 6.16 | 0.6356 | 0.7178 | 0.8922 | -- | 0.1996 | 13.92 | 9.92 | 5.30 | 1.28 | 1.51 | -5.34 | 5.92 |
| Fuso Pharmaceutical Industries Ltd | 55.41bn | 1.38bn | 22.20bn | 1.31k | 14.70 | 0.5475 | 6.20 | 0.4007 | 159.76 | 159.76 | 6,434.77 | 4,290.49 | 0.7474 | 3.12 | 2.43 | 42,392,500.00 | 1.86 | 1.91 | 3.06 | 3.09 | 24.98 | 26.92 | 2.49 | 2.69 | 1.04 | 54.56 | 0.2576 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Astena Holdings Co Ltd | 52.63bn | 1.62bn | 23.32bn | 1.40k | 13.89 | 0.7876 | 6.06 | 0.4431 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| TAIKO PHARMACEUTICAL CO LTD | 6.33bn | -2.90bn | 23.50bn | 208.00 | -- | 3.13 | -- | 3.71 | -58.49 | -58.49 | 129.20 | 148.04 | 0.462 | 2.04 | 3.44 | 30,432,690.00 | -21.14 | -- | -26.00 | -- | 44.27 | -- | -45.75 | -- | 2.92 | -- | 0.2811 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| StemRIM Inc | 0.00 | -2.13bn | 27.19bn | 44.00 | -- | 2.90 | -- | -- | -34.87 | -34.87 | 0.00 | 152.36 | 0.00 | -- | -- | 0.00 | -20.52 | -6.71 | -20.87 | -6.83 | -- | -- | -- | -45.80 | 99.90 | -8,295.36 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
| CellSeed Inc | 193.68m | -892.21m | 33.58bn | 35.00 | -- | 15.00 | -- | 173.38 | -29.71 | -29.71 | 6.47 | 64.75 | 0.088 | 1.63 | 7.62 | 5,533,600.00 | -40.53 | -49.69 | -43.83 | -54.55 | 56.58 | 63.66 | -460.67 | -428.62 | 19.14 | -- | 0.0669 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Daito Pharmaceutical Co Ltd | 46.90bn | 3.30bn | 33.74bn | 1.01k | 10.22 | 0.6312 | 6.93 | 0.7194 | 210.18 | 210.18 | 2,988.73 | 3,404.72 | 0.6326 | 1.89 | 2.96 | -- | 4.29 | 6.27 | 5.58 | 8.24 | 20.98 | 22.65 | 6.78 | 8.47 | 1.11 | -- | 0.143 | 18.48 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
Data as of Jul 17 2024. Currency figures normalised to Astena Holdings Co Ltd's reporting currency: Japanese Yen JPY
10.75%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 31 May 2024 | 1.27m | 3.09% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 1.15m | 2.81% |
| Nikko Asset Management Co., Ltd.as of 05 Jul 2024 | 580.90k | 1.42% |
| Daiwa Asset Management Co. Ltd.as of 31 May 2024 | 548.90k | 1.34% |
| SPARX Asset Management Co., Ltd.as of 23 Jan 2023 | 340.30k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Jul 2024 | 238.80k | 0.58% |
| Dimensional Fund Advisors Ltd.as of 04 Jul 2024 | 94.77k | 0.23% |
| BlackRock Japan Co. Ltd.as of 04 Jul 2024 | 69.40k | 0.17% |
| Asset Management One Co., Ltd.as of 04 Jul 2024 | 58.80k | 0.14% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 04 Jul 2024 | 54.80k | 0.13% |
More ▼
Data from 31 Mar 2024 - 11 Jul 2024Source: FactSet Research Systems Inc.
